ELMWOOD PARK, N.J., April 27, 2021 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced its renewal as the COVID-19 testing provider for Major League Soccer ...

BioReference Laboratories Inc. in Elmwood Park entered into a COVID-19 testing agreement for players and staff, stadium employees and league staff for the 2021 Major League Baseball season. Under the ...

ELMWOOD PARK, N.J., Dec. 12, 2017 /PRNewswire/ -- BioReference Laboratories, Inc., one of the nation's largest, full-service clinical diagnostic laboratories, applauds the American Clinical Laboratory ...

BioReference Health, formerly known as BioReference Laboratories, and OPKO Health have agreed to pay $9.85 million to resolve alleged violations of the False Claims Act arising from BioReference’s ...

BioReference Laboratories Inc. in Elmwood Park acquired the U.S. Ariosa centralized laboratory prenatal testing business from Roche. The Harmony Prenatal Test, Ariosa’s non-invasive prenatal screening ...

The NFL uses BioReference Laboratories for its COVID-19 testing Using a private lab doesn't add to the volume of local testing NFL teams get most test results back in 24 hours The Jaguars and 31 other ...

Monday - Friday, 6:00 - 7:00 PM ET BioReference Laboratories will handle Covid-19 testing for all 32 NFL teams this season, Executive Chairman Dr. Jon Cohen told CNBC's Jim Cramer. The private company ...

BioReference Health LLC, formerly known as BioReference Laboratories Inc. (BioReference) and OPKO Health Inc. (OPKO), face a $704,349 government fine for medically unnecessary blood tests. The ...

Ariosa's non invasive prenatal screening (NIPS) test, the Harmony Prenatal Test, is one of the most widely studied tests utilized in prenatal screening. The test has been performed in over 1.5 million ...

Although we don't believe intiming the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares ...

ELMWOOD PARK, N.J.—In early July, as coronavirus surged across the U.S., one of the nation’s biggest laboratories involved in testing for Covid-19 made a wrenching decision: It would stop accepting ...